【纳斯达克上市公司BioNexus Gene Lab宣布采用以太坊财务储备战略】金色财经报道，据Globenewswire报道，致力于技术创新与医疗保健的科技公司BioNexus Gene Lab Corp.（纳斯达克股票代码：BGLC）宣布，其董事会已正式批准公司新的以太坊专注型财务战略。此决策标志着BGLC成为首家将以太坊作为战略财务资产独家优先考虑的纳斯达克上市公司，并与近期以太坊被纳入美国“加密货币战略储备”的公告相呼应。 同时，BGLC发布了以太坊战略白皮书，详细阐述了公司决策背后的理由，以及以太坊作为金融基础设施资产更广泛的意义。白皮书深入探讨了以太坊在机构中的采用情况、质押能力，以及即将进行的协议升级，这些升级巩固了以太坊的长期价值和对企业而言的实用性。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.